Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study.

BACKGROUND: Open-angle glaucoma (OAG) is a progressive neurodegenerative disease that may lead to blindness. An elevated intraocular pressure (IOP) is its major risk factor. OAG treatment is currently exclusively directed towards the lowering of the IOP. IOP lowering does not prevent disease progres...

Full description

Bibliographic Details
Main Authors: Michael W Marcus, Rogier P H M Müskens, Wishal D Ramdas, Roger C W Wolfs, Paulus T V M De Jong, Johannes R Vingerling, Albert Hofman, Bruno H Stricker, Nomdo M Jansonius
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3251600?pdf=render